Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsAGERO, Anna Liza C; DUSZA, Stephen W; BENVENUTO-ANDRADE, Cristiane et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 4, pp 657-670, issn 0190-9622, 14 p.Article

Novel combinations based on epidermal growth factor receptor inhibitionADJEI, Alex A.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4446s-4450s, 2Conference Paper

Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647GENDREAU, Steven B; VENTURA, Richard; JACKMAN, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3713-3723, issn 1078-0432, 11 p.Article

Cetuximab : Significant clinical value after platinum failureJournal of cancer research and clinical oncology. 2006, Vol 132, pp 11-13, issn 0171-5216, 3 p., SUP3Conference Paper

Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. CommentaryDEWITT, Christine A; SIROY, Alan E; STONE, Stephen P et al.Journal of the American Academy of Dermatology. 2007, Vol 56, Num 3, issn 0190-9622, 500-505, 514-517 [10 p.]Article

Visualizing the dynamics of EGFR activity and antiglioma therapies In vivoARWERT, Esther; HINGTGEN, Shawn; FIGUEIREDO, Jose-Luiz et al.Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7335-7342, issn 0008-5472, 8 p.Article

A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivoRAJPUT, Ashwani; KOTERBA, Alan P; KREISBERG, Jeffrey I et al.Cancer research (Baltimore). 2007, Vol 67, Num 2, pp 665-673, issn 0008-5472, 9 p.Article

Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitorsALEXANDRESCU, D. T; VAILLANT, J. G; DASANU, C. A et al.Clinical and experimental dermatology (Print). 2007, Vol 32, Num 1, pp 71-74, issn 0307-6938, 4 p.Article

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningJÄNNE, Pasi A; BORRAS, Ana M; DISTEL, Robert J et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 751-758, issn 1078-0432, 8 p., 1Article

Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnoverOLABISI, Oyenike O; MAHON, Gwendolyn M; KOSTENKO, Elena V et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6250-6257, issn 0008-5472, 8 p.Article

Critical update and emerging trends in epidermal growth factor receptor targeting in cancerBASELGA, José; ARTEAGA, Carlos L.Journal of clinical oncology. 2005, Vol 23, Num 11, pp 2445-2459, issn 0732-183X, 15 p.Article

Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agentsJIMENO, Antonio; RUBIO-VIQUEIRA, Belen; AMADOR, Maria L et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3003-3010, issn 0008-5472, 8 p.Article

Molecular determinants of cetuximab efficacyVALLBÖHMER, Daniel; WU ZHANG; GROSHEN, Susan et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3536-3544, issn 0732-183X, 9 p.Article

Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGFa prior to neoplasiaCHARALAMBOUS, Chrystalla T; HANNIGAN, Adele; TSIMBOURI, Penelope et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 8, pp 1839-1848, issn 0143-3334, 10 p.Article

The phosphoinositide kinase pkfyve mediates epidermal growth factor receptor trafficking to the nucleusKIM, Jayoung; WAN JIN JAHNG; DI VINO, Dolores et al.Cancer research (Baltimore). 2007, Vol 67, Num 19, pp 9229-9237, issn 0008-5472, 9 p.Article

Les inhibiteurs de l'EGFR = EGFR inhibitorsMILLERON, Bernard.Revue de pneumologie clinique (Paris). 2007, Vol 63, Num 1, issn 0761-8417, 20 p., CAH2Serial Issue

Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLEHASSON, P; PAROUSH, Z.British journal of cancer. 2006, Vol 94, Num 6, pp 771-775, issn 0007-0920, 5 p.Article

ErbB3-dependent motility and intravasation in breast cancer metastasisCHENGSEN XUE; FUBO LIANG; SEGALL, Jeffrey E et al.Cancer research (Baltimore). 2006, Vol 66, Num 3, pp 1418-1426, issn 0008-5472, 9 p.Article

The epidermal growth factor receptor pathway : A model for targeted therapy : Predictive preclinical models of human cancer: Mouse models get another chanceSCALTRITI, Maurizio; BASELGA, José.Clinical cancer research. 2006, Vol 12, Num 18, pp 5268-5272, issn 1078-0432, 5 p.Article

Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptorXU, Ke-Ping; JIA YIN; YU, Fu-Shin X et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 2, pp 636-643, issn 0146-0404, 8 p.Article

Molecular context of the EGFR mutations : Evidence for the activation of mTOR/S6K signalingCONDE, Esther; ANGULO, Barbara; MOYING TANG et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 710-717, issn 1078-0432, 8 p., 1Article

Cetuximab prolongs survival and improves locoregional controlJournal of cancer research and clinical oncology. 2006, Vol 132, pp 6-9, issn 0171-5216, 4 p., SUP3Conference Paper

Epidermal growth factor receptor targeting in cancerMENDELSOHN, John; BASELGA, Jose.Seminars in oncology. 2006, Vol 33, Num 4, pp 369-385, issn 0093-7754, 17 p.Article

Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptorTIMPSON, Paul; LYNCH, Danielle K; SCHRAMEK, Daniel et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3273-3280, issn 0008-5472, 8 p.Article

Photochemical targeting of epidermal growth factor receptor: A mechanistic studySAVELLANO, Mark D; HASAN, Tayyaba.Clinical cancer research. 2005, Vol 11, Num 4, pp 1658-1668, issn 1078-0432, 11 p.Article